- Report
- August 2026
- 368 Pages
Global
From €5254EUR$5,850USD£4,488GBP
- Report
- July 2026
- 115 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- June 2026
- 115 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- June 2026
- 132 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- May 2026
- 350 Pages
Global
From €4445EUR$4,949USD£3,797GBP
- Report
- May 2026
- 350 Pages
Global
From €4445EUR$4,949USD£3,797GBP
- Report
- March 2026
- 197 Pages
Global
From €4486EUR$4,995USD£3,832GBP
- Report
- February 2026
- 199 Pages
Global
From €4486EUR$4,995USD£3,832GBP
- Report
- April 2026
- 160 Pages
Global
From €2982EUR$3,320USD£2,547GBP
€3727EUR$4,150USD£3,184GBP
- Report
- April 2026
- 160 Pages
Global
From €2982EUR$3,320USD£2,547GBP
€3727EUR$4,150USD£3,184GBP
- Report
- April 2026
- 160 Pages
Global
From €2982EUR$3,320USD£2,547GBP
€3727EUR$4,150USD£3,184GBP
- Report
- January 2026
- 160 Pages
Global
From €2838EUR$3,160USD£2,424GBP
€3548EUR$3,950USD£3,031GBP
- Report
- October 2025
- 160 Pages
Global
From €2838EUR$3,160USD£2,424GBP
€3548EUR$3,950USD£3,031GBP
- Report
- April 2026
- 160 Pages
Global
From €2982EUR$3,320USD£2,547GBP
€3727EUR$4,150USD£3,184GBP
- Report
- April 2026
- 160 Pages
Global
From €2982EUR$3,320USD£2,547GBP
€3727EUR$4,150USD£3,184GBP
- Report
- April 2026
- 160 Pages
Global
From €2982EUR$3,320USD£2,547GBP
€3727EUR$4,150USD£3,184GBP
- Report
- November 2025
- 160 Pages
Global
From €2838EUR$3,160USD£2,424GBP
€3548EUR$3,950USD£3,031GBP
- Report
- October 2025
- 160 Pages
Global
From €2838EUR$3,160USD£2,424GBP
€3548EUR$3,950USD£3,031GBP
- Report
- April 2026
- 95 Pages
Global
From €3500EUR$4,174USD£3,094GBP
- Report
- April 2026
- 108 Pages
Global
From €3500EUR$4,174USD£3,094GBP

The Neurotech market is a subset of the Neurology Devices industry, focusing on the development and commercialization of products and services related to the diagnosis, treatment, and management of neurological disorders. Neurotech products range from medical devices such as brain-computer interfaces, deep brain stimulation systems, and neuroprosthetics, to software and digital health solutions such as brain-computer interfaces, virtual reality, and artificial intelligence. Neurotech companies are also developing novel treatments for neurological disorders, such as gene therapy, stem cell therapy, and gene editing.
The Neurotech market is driven by advances in technology, increasing prevalence of neurological disorders, and growing demand for personalized treatments. Neurotech companies are also leveraging the power of data to develop more effective treatments and improve patient outcomes.
Notable companies in the Neurotech market include NeuroPace, NeuroMetrix, BrainScope, NeuroSigma, NeuroVista, and NeuroSens. Show Less Read more